Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- New treatments, advances changing outcomes for radioactive iodine-refractory thyroid cancer
-
- A conversation with pediatric obesity researcher Denise Wilfley, PhD
- Guidance needed for dietary supplement use in diabetes Susan Weiner, MS, RDN, CDN, CDCES, FADCES
- Autoimmune thyroid disease, retinopathy may signal Addison’s disease in type 1 diabetes
- Cost, expected weight loss primary factors in opting for bariatric surgery
- Gelesis100 shows promise for weight loss in adults with obesity
- Hormonal contraception may cause bone loss in adolescent girls
- Influence of HbA1c on fracture risk differs in type 1, type 2 diabetes
- Insulin glargine, lixisenatide combination safe, effective for older adults with type 2 diabetes
-
- Interventions for couples yield benefits for partners of adults with type 2 diabetes
- Long-term follow-up needed after gamma knife radiosurgery for acromegaly
- Low-carb diets show promise in improving glycemic measures
- Metformin fails to improve birth outcomes in pregnancy with obesity
- No association between long-term GH replacement, comorbidities in nonfunctioning pituitary adenoma
- No urinary tract infection risk with most SGLT2 inhibitors
- Omega-3s may provide no cardiovascular health benefit
- Parental monitoring can positively affect adolescent weight status
-
- Prenatal drug exposure may influence stress response, obesity risk in teen girls
- Thyroid storm substantially increases hospital mortality
- Type 2 diabetes may cause erectile dysfunction
- VIDEO: Sleep plays key role in cardiometabolic health
- Should lenvatinib or sorafenib be the first agent used in slowly progressing radioiodine-refractory thyroid carcinoma?